Association between intestinal permeability and anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease.
Benjamin
Jaya
J
Makharia
Govind K
GK
Joshi
Yogendra K
YK
D000974:Antibodies, Antinuclear / Q000032:analysis*; D000908:Antibodies, Fungal; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D003424:Crohn Disease / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007074:Immunoglobulin G / Q000378:metabolism; D007413:Intestinal Mucosa / Q000276:immunology / Q000378:metabolism*; D007792:Lactulose / Q000493:pharmacokinetics; D008297:Male; D008353:Mannitol / Q000493:pharmacokinetics*; D010539:Permeability; D012016:Reference Values; D012440:Saccharomyces / Q000276:immunology*; D012680:Sensitivity and Specificity
D000974:Antibodies, Antinuclear; D000908:Antibodies, Fungal; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008353:Mannitol; D007792:Lactulose